Myelodysplastic syndromes (MDS)

Why this name covers more than one condition

MDS is not one condition. The 2022 WHO classification separates it by what is actually driving the marrow to misbehave — how many immature cells are present, and which genetic changes are there. But the thing that decides treatment is not the subtype name: it is a risk score, called IPSS-R or the newer IPSS-M, which weighs the blast count, the chromosome findings, how low the blood counts are, and gene results together. The transplant guidance is written against those risk bands, not against the subtype labels. These subtypes typically fall into different bands, which is why they have separate pages here — but typically is not always, and the score is what applies to a person.

The conditions under this name

• Myelodysplastic neoplasm with increased blasts

  For some people with this condition, a transplant using blood stem cells from an unrelated donor is part of the treatment guidelines. When a transplant is the right route and no one in the family matches, that donor comes from a registry. Not everyone with this condition has a transplant, and many never need one.

  A stranger can be the match

• Myelodysplastic neoplasm with biallelic TP53 inactivation

  For some people with this condition, a transplant using blood stem cells from an unrelated donor is part of the treatment guidelines. When a transplant is the right route and no one in the family matches, that donor comes from a registry. Not everyone with this condition has a transplant, and many never need one.

  A stranger can be the match

• Myelodysplastic neoplasm with low blasts and isolated 5q deletion

  A transplant is not a standard part of treating this condition. It is used rarely, in particular situations, and most people diagnosed with it will not have one.

  Transplant is not the usual treatment

• Myelodysplastic neoplasm with low blasts and SF3B1 mutation

  A transplant is not a standard part of treating this condition. It is used rarely, in particular situations, and most people diagnosed with it will not have one.

  Transplant is not the usual treatment